BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 32862492)

  • 1. Knockdown of lncRNA ZNRD1-AS1 inhibits progression of bladder cancer by regulating miR-194 and ZEB1.
    Gao Z; Li S; Zhou X; Li H; He S
    Cancer Med; 2020 Oct; 9(20):7695-7705. PubMed ID: 32862492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 4. Knockdown of lncRNA ZNRD1-AS1 suppresses gastric cancer cell proliferation and metastasis by targeting the miR-9-5p/HSP90AA1 axis.
    Ba MC; Ba Z; Gong YF; Lin KP; Wu YB; Tu YN
    Aging (Albany NY); 2021 Jul; 13(13):17285-17301. PubMed ID: 34226297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 7. LncRNA TTN-AS1 drives invasion and migration of lung adenocarcinoma cells via modulation of miR-4677-3p/ZEB1 axis.
    Zhong Y; Wang J; Lv W; Xu J; Mei S; Shan A
    J Cell Biochem; 2019 Oct; 120(10):17131-17141. PubMed ID: 31173403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A TP73-AS1/miR-200a/ZEB1 regulating loop promotes breast cancer cell invasion and migration.
    Zou Q; Zhou E; Xu F; Zhang D; Yi W; Yao J
    J Cell Biochem; 2018 Feb; 119(2):2189-2199. PubMed ID: 28857253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
    Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis.
    Peng Z; Ouyang X; Wang Y; Fan Q
    BMC Mol Cell Biol; 2022 Apr; 23(1):21. PubMed ID: 35468721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding ribonucleic acid zinc finger E-box binding homeobox 1 antisense RNA 1 regulates myocardial fibrosis in diabetes through the Hippo-Yes-associated protein signaling pathway.
    Wu J; Lyu R; Chen S; Wang X
    J Diabetes Investig; 2023 Aug; 14(8):940-952. PubMed ID: 37309277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c.
    Xue S; Lu F; Sun C; Zhao J; Zhen H; Li X
    World J Surg Oncol; 2021 Apr; 19(1):121. PubMed ID: 33865414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.
    Liu X; Zhao W; Wang X
    Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
    Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
    Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m
    Wang J; Tan L; Yu X; Cao X; Jia B; Chen R; Li J
    Mol Cancer; 2022 Dec; 21(1):229. PubMed ID: 36581942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
    Zhou Y; Feng D; Gu X; Gao A; Liu Y
    Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNA ZEB1-Antisense 1 Affects Cell Migration and Invasion of Cervical Cancer by Regulating Epithelial-Mesenchymal Transition via the p38MAPK Signaling Pathway.
    Gan L; Chen Y; Liu H; Ju WH
    Gynecol Obstet Invest; 2019; 84(2):136-144. PubMed ID: 30253398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircRNA DNA methyltransferase 1 silence inhibits breast cancer development by regulating micoRNA-485-3p/zinc finger E-box binding homeobox 1 axis.
    Xie C; Li J; Xu C; Xiong W; Yuan X
    J Obstet Gynaecol Res; 2021 Mar; 47(3):1068-1081. PubMed ID: 33403756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
    Xue M; Pang H; Li X; Li H; Pan J; Chen W
    Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.